Neuronetics, Inc.
STIM
$1.24
-$0.04-3.13%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 69.52% | 99.17% | 78.62% | 54.17% | 22.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 69.52% | 99.17% | 78.62% | 54.17% | 22.16% |
| Cost of Revenue | 145.07% | 279.80% | 304.36% | 177.12% | 78.70% |
| Gross Profit | 27.37% | 32.77% | 16.08% | 15.15% | 3.82% |
| SG&A Expenses | 14.75% | 27.92% | 26.34% | 22.81% | 16.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.61% | 65.53% | 69.97% | 50.54% | 29.08% |
| Operating Income | 23.88% | 8.63% | -45.45% | -40.76% | -48.88% |
| Income Before Tax | 23.31% | 10.50% | -22.48% | -49.51% | -76.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 23.31% | 10.50% | -22.48% | -49.51% | -76.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 242.42% | 621.05% | -- | -- | -- |
| Net Income | 23.49% | 10.78% | -22.18% | -50.27% | -76.13% |
| EBIT | 23.88% | 8.63% | -45.45% | -40.76% | -48.88% |
| EBITDA | 27.97% | 13.61% | -45.08% | -41.69% | -51.22% |
| EPS Basic | 58.58% | 56.71% | 31.26% | -3.68% | -39.07% |
| Normalized Basic EPS | 54.00% | 51.48% | 18.56% | 5.25% | -17.41% |
| EPS Diluted | 58.58% | 56.71% | 31.26% | -3.68% | -39.07% |
| Normalized Diluted EPS | 54.00% | 51.48% | 18.56% | 5.25% | -17.41% |
| Average Basic Shares Outstanding | 71.55% | 108.52% | 94.91% | 65.68% | 36.62% |
| Average Diluted Shares Outstanding | 71.55% | 108.52% | 94.91% | 65.68% | 36.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |